-transparent.png){kind=logo}
167 women were treated with 0.5 mg lynestrenol/day for a period of 8-32 weeks immediately postpartum. The lactation periods of 67 of the women were observed during the stay in hospital (maximum 7 days) in comparison with a control group (n = 20) of untreated women in the puerperium. There was no quantitative difference in milk production between the lynestrenol-treated women and the control group. In order to exclude a possible thromboembolic effect the lynestrenol the thrombocyte aggregation was determined in all women at 4-weekly intervals as a measure of a thrombotic tendency. During the entire period of the investigation the mean PAT rating remained between I and II. Among the clinical parameters a raised amenorrhea rate of 21% and a larger proportion (39%) of breakthrough bleedings were notable. The responded easily to treatment.
L Mettler, and
M Müller, and
F W Dittmar, and
K Semm
January 1970,
Acta medica Academiae Scientiarum Hungaricae,
L Mettler, and
M Müller, and
F W Dittmar, and
K Semm
November 1973,
Ceskoslovenska gynekologie,
L Mettler, and
M Müller, and
F W Dittmar, and
K Semm
January 1987,
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
L Mettler, and
M Müller, and
F W Dittmar, and
K Semm
December 1976,
Wiener klinische Wochenschrift,
L Mettler, and
M Müller, and
F W Dittmar, and
K Semm
January 1982,
Reproduccion,
L Mettler, and
M Müller, and
F W Dittmar, and
K Semm
January 1982,
Contraceptive delivery systems,
L Mettler, and
M Müller, and
F W Dittmar, and
K Semm
April 1993,
Annals of medicine,
L Mettler, and
M Müller, and
F W Dittmar, and
K Semm
June 2001,
Harefuah,
L Mettler, and
M Müller, and
F W Dittmar, and
K Semm
November 1977,
Therapeutische Umschau. Revue therapeutique,
L Mettler, and
M Müller, and
F W Dittmar, and
K Semm
January 1978,
Annales d'endocrinologie,
